scholarly article | Q13442814 |
P819 | ADS bibcode | 2003PNAS..10012325G |
P356 | DOI | 10.1073/PNAS.2033229100 |
P953 | full work available at URL | https://europepmc.org/articles/PMC218757 |
https://europepmc.org/articles/pmc218757?pdf=render | ||
https://doi.org/10.1073/pnas.2033229100 | ||
https://europepmc.org/articles/PMC218757?pdf=render | ||
https://pnas.org/doi/pdf/10.1073/pnas.2033229100 | ||
P932 | PMC publication ID | 218757 |
P698 | PubMed publication ID | 14528005 |
P5875 | ResearchGate publication ID | 9064252 |
P2093 | author name string | James A. Richardson | |
John M. Shelton | |||
Praveena Gupta | |||
Sandra L. Hofmann | |||
Krystyna E. Wisniewski | |||
Abigail A. Soyombo | |||
Ian G. Wilkofsky | |||
P2860 | cites work | Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase | Q24308145 |
Molecular cloning and expression of palmitoyl-protein thioesterase 2 (PPT2), a homolog of lysosomal palmitoyl-protein thioesterase with a distinct substrate specificity | Q24320100 | ||
Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis | Q24322669 | ||
Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice | Q24555093 | ||
The crystal structure of palmitoyl protein thioesterase-2 (PPT2) reveals the basis for divergent substrate specificities of the two lysosomal thioesterases, PPT1 and PPT2 | Q27641662 | ||
Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras | Q28626381 | ||
Molecular cloning and expression of palmitoyl-protein thioesterase | Q28626396 | ||
Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: Review of data and observations | Q30830725 | ||
Structure of the human palmitoyl-protein thioesterase-2 gene (PPT2) in the major histocompatibility complex on chromosome 6p21.3. | Q33853637 | ||
Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease). | Q34448891 | ||
The mousetrap: what we can learn when the mouse model does not mimic the human disease | Q34578759 | ||
Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. | Q37383913 | ||
TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement | Q38472345 | ||
Animal models of lysosomal disease: an overview | Q38578684 | ||
Mouse models of human lysosomal diseases. | Q40870650 | ||
Diagnosis of neurometabolic disorders by examination of skin biopsies and lymphocytes. | Q48681062 | ||
Phenotype analysis in neurological models of human disease | Q74675128 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 12325-12330 | |
P577 | publication date | 2003-10-03 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Disruption of PPT2 in mice causes an unusual lysosomal storage disorder with neurovisceral features | |
Disruption ofPPT2in mice causes an unusual lysosomal storage disorder with neurovisceral features | |||
P478 | volume | 100 |
Q37462041 | A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera. |
Q42028708 | Characterization of a serine hydrolase targeted by acyl-protein thioesterase inhibitors in Toxoplasma gondii |
Q34427575 | Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses |
Q33779818 | Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy |
Q33306146 | Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response |
Q37145569 | Identification of differentially expressed genes by gabapentin in cultured dorsal root ganglion in a rat neuropathic pain model |
Q48173099 | Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis |
Q30477117 | Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease |
Q38236849 | Palmitoylation and depalmitoylation defects |
Q92412421 | Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474 |
Q35681068 | Selectivity and types of cell death in the neuronal ceroid lipofuscinoses |
Q24617469 | The Drosophila protein palmitoylome: characterizing palmitoyl-thioesterases and DHHC palmitoyl-transferases |
Q35825859 | The cell biology of lysosomal storage disorders |
Q34302797 | The genetic spectrum of human neuronal ceroid-lipofuscinoses |
Q35792475 | The idiopathic preterm delivery methylation profile in umbilical cord blood DNA. |
Q35681065 | The intracellular location and function of proteins of neuronal ceroid lipofuscinoses |
Q35333042 | The metabolic serine hydrolases and their functions in mammalian physiology and disease |
Search more.